Acquisition maintains Focus on Medical Devices

The Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology, have been acquired by Noventure, specialised in licensing medical devices and food supplements. The medical devices were originally developed by Spanish companies Quesper R&D and Orpea Ibérica, together with the Andalusian Health Service (Servicio Andaluz de Salud, SAS).

Luciano Conde, CEO of Noventure, said: “This agreement will enable us to keep shaping innovative science assets and bring them to markets around the world, and to take steps towards becoming a key player in medical devices for topical applications. This is only the beginning; we have many innovative products that we will be able to bring to patients, thanks to this patented new technology.”

Ulkox and Oleoabrax, the first Olea Europaea-based products for Noventure, are already available for licensing. Certified as Class IIb medical devices, they are indicated for healing skin wounds of full or partial thickness. As amorphous hydrogels, they protect the affected area from infection and boost healing based on four properties: the protective barrier, skin hydration, pH control and oxygen radical scavenging effect.

More information online